Latest News

March 17, 2020

Lyssiotis Lab Makes It to Sweet 16 Round of STAT Madness!

Best of luck to the Lyssiotis Lab as they proceed to compete in the second round of STAT Madness! Their research demonstrates how pancreatic tumors neutralize the effects of gemcitabine chemotherapy through the attraction and manipulation of macrophages.

Timothy Graubert
January 15, 2020

Dr. Timothy Graubert Lunch With Trainees

The Doctoral Program in Cancer Biology welcomes Dr. Timothy Graubert, M.D., Professor of Medicine, Harvard Medical School, Director of Hematologic Malignancies, Mass General Cancer Center .

Samuel Kerk
December 18, 2019

Sam Kerk (Lyssiotis Lab) Awarded F31 Grant

Congratulations to Sam Kerk , who was awarded an F31 award, which supports promising doctoral candidates who will perform dissertation research and training for a PhD degree in a scientific health-related field. The Fellowship will cover his stipend, tuition,